{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:17:08Z","timestamp":1791037028280,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,12,20]],"date-time":"2009-12-20T00:00:00Z","timestamp":1261267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s10689-009-9313-1","type":"journal-article","created":{"date-parts":[[2009,12,19]],"date-time":"2009-12-19T10:31:26Z","timestamp":1261218686000},"page":"297-304","source":"Crossref","is-referenced-by-count":42,"title":["Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain"],"prefix":"10.1007","volume":"9","author":[{"given":"Judit","family":"Sanz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Ram\u00f3n y Cajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asunci\u00f3n","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Darder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Gadea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fortuny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consol","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fisas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carmen","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Balma\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,20]]},"reference":[{"key":"9313_CR1","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/1078-0432.CCR-07-4436","volume":"14","author":"RL Milne","year":"2008","unstructured":"Milne RL, Osorio A, Ramon y Cajal T et al (2008) The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counselling units in Spain. Clin Cancer Res 14:2861\u20132869","journal-title":"Clin Cancer Res"},{"key":"9313_CR2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1200\/JCO.1994.12.4.843","volume":"12","author":"C Lerman","year":"1994","unstructured":"Lerman C, Daly M, Masny A, Balshem A (1994) Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12:843\u2013850","journal-title":"J Clin Oncol"},{"key":"9313_CR3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ajmg.1320570304","volume":"57","author":"C Lerman","year":"1995","unstructured":"Lerman C, Seay J, Balshem A, Audrain J (1995) Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 57:385\u2013392","journal-title":"Am J Med Genet"},{"key":"9313_CR4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/109065703322537241","volume":"7","author":"C Blandy","year":"2003","unstructured":"Blandy C, Chabal F, Stoppa-Lyonnet D, Julian-Reynier C (2003) Testing participation in BRCA1\/2-positive families: initiator role of index cases. Genet Test 7:225\u2013233","journal-title":"Genet Test"},{"key":"9313_CR5","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1200\/JCO.2006.09.1900","volume":"25","author":"AR Bradbury","year":"2007","unstructured":"Bradbury AR, Dignam JJ, Ibe CN et al (2007) How often do BRCA mutation carriers tell their young children of the family\u2019s risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults. J Clin Oncol 25:3705\u20133711","journal-title":"J Clin Oncol"},{"key":"9313_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/gte.2007.0037","volume":"12","author":"E Finlay","year":"2008","unstructured":"Finlay E, Stopfer JE, Burlingame E et al (2008) Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1\/2 mutations. Genet Test 12:81\u201391","journal-title":"Genet Test"},{"key":"9313_CR7","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1200\/JCO.1998.16.5.1650","volume":"16","author":"C Lerman","year":"1998","unstructured":"Lerman C, Hughes C, Lemon SJ et al (1998) What you don\u2019t know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol 16:1650\u20131654","journal-title":"J Clin Oncol"},{"key":"9313_CR8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10689-004-7991-2","volume":"4","author":"K Landsbergen","year":"2005","unstructured":"Landsbergen K, Verhaak C, Kraaimaat F, Hoogerbrugge N (2005) Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Fam Cancer 4:115\u2013119","journal-title":"Fam Cancer"},{"key":"9313_CR9","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1200\/JCO.2005.01.7541","volume":"24","author":"AF Patenaude","year":"2006","unstructured":"Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE (2006) Sharing BRCA1\/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol 24:700\u2013706","journal-title":"J Clin Oncol"},{"key":"9313_CR10","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/ejhg.2008.17","volume":"16","author":"SM Holloway","year":"2008","unstructured":"Holloway SM, Bernhard B, Campbell H, Lam WW (2008) Uptake of testing for BRCA1\/\/2 mutations in South East Scotland. Eur Jour Hum Genet 16:906\u2013912","journal-title":"Eur Jour Hum Genet"},{"key":"9313_CR11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1099-1611(200011\/12)9:6<504::AID-PON491>3.0.CO;2-R","volume":"9","author":"C Julian-Reynier","year":"2000","unstructured":"Julian-Reynier C, Sobol H, S\u00e9villa C, Nogu\u00e8s C, Bourret P (2000) The French cancer genetic network: uptake of hereditary breast\/ovarian cancer genetic testing in a French national sample of BRCA1 families. Psychooncology 9:504\u2013510","journal-title":"Psychooncology"},{"key":"9313_CR12","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.1996.03530480027036","volume":"275","author":"C Lerman","year":"1996","unstructured":"Lerman C, Narod S, Schulman K et al (1996) BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 275:1885\u20131892","journal-title":"JAMA"},{"key":"9313_CR13","unstructured":"OncoGuia del consell i assessorament gen\u00e8tics en c\u00e0ncer hereditaris. Versi\u00f3 completa. Ag\u00e8ncia d\u2019Avaluaci\u00f3 de Tecnologia i Recerca M\u00e8diques. CatSalut. Departament de Salut. Generalitat de Catalunya; Barcelona. Catalunya (Espanya). OG012006. http:\/\/www.gencat.net\/salut\/depsan\/units\/aatrm\/html\/en\/dir398\/index.html (English version) 2006"},{"key":"9313_CR14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1099-1611(200011\/12)9:6<522::AID-PON492>3.0.CO;2-S","volume":"9","author":"L Hagoel","year":"2000","unstructured":"Hagoel L, Dishon S, Almog R, Silman Z, Bisland-Becktell S, Rennert G (2000) Proband family uptake of familial-genetic counselling. Psychooncology 9:522\u2013527","journal-title":"Psychooncology"},{"key":"9313_CR15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1023\/A:1025864703405","volume":"12","author":"TL Bodd","year":"2003","unstructured":"Bodd TL, Reichelt J, Heimdal K, Moller P (2003) Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway. J Genet Couns 12:405\u2013417","journal-title":"J Genet Couns"},{"key":"9313_CR16","first-page":"1251","volume":"9","author":"K Armstrong","year":"2000","unstructured":"Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B (2000) Factors associated with decisions about clinical BRCA1\/2 testing. Cancer Epidemiol Biomarkers Prev 9:1251\u20131254","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9313_CR17","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(00)02347-3","volume":"355","author":"EJ Meijers-Heijboer","year":"2000","unstructured":"Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT et al (2000) Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 355:2015\u20132020","journal-title":"Lancet"},{"key":"9313_CR18","first-page":"169","volume":"4","author":"JP Struewing","year":"1995","unstructured":"Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA (1995) Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 4:169\u2013173","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9313_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/gte.2006.9998","volume":"11","author":"B Godard","year":"2007","unstructured":"Godard B, Pratte A, Dumont M, Simard-Lebrun A, Simard J (2007) Factors associated with an individual\u2019s decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling. Genet Test 11:45\u201354","journal-title":"Genet Test"},{"key":"9313_CR20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","volume":"351","author":"M Kriege","year":"2004","unstructured":"Kriege M, Brekelmans CTM, Boetes C et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427\u2013437","journal-title":"N Engl J Med"},{"key":"9313_CR21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/sj.bjc.6600253","volume":"86","author":"C Foster","year":"2002","unstructured":"Foster C, Evans DG, Eeles R et al (2002) Predictive testing for BRCA1\/2: attributes, risk perception and management in a multi-centre clinical cohort. Br J Cancer 86:1209\u20131216","journal-title":"Br J Cancer"},{"key":"9313_CR22","first-page":"377","volume":"8","author":"G Geller","year":"1999","unstructured":"Geller G, Doksum T, Bernhardt BA, Metz SA (1999) Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women\u2019s decisions. Cancer Epidemiol Biomarkers Prev 8:377\u2013383","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9313_CR23","first-page":"906","volume":"36","author":"LN Lodder","year":"1999","unstructured":"Lodder LN, Frets PG, Trijsburg RW et al (1999) Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam\/Leiden Genetics Working Group. J Med Genet 36:906\u2013913","journal-title":"J Med Genet"},{"key":"9313_CR24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000164684","volume":"12","author":"C Molster","year":"2009","unstructured":"Molster C, Charles T, Samanek A, O\u2019Leary P (2009) Australian study on public knowledge of human genetics and health. Public Health Genomics 12:84\u201391","journal-title":"Public Health Genomics"},{"key":"9313_CR25","first-page":"33","volume":"7","author":"L Henneman","year":"2004","unstructured":"Henneman L, Timmermans DR, van der Wal G (2004) Public experiences, knowledge and expectations about medical genetics and the use of genetic information. Community Genet 7:33\u201343","journal-title":"Community Genet"},{"key":"9313_CR26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pec.2006.07.005","volume":"65","author":"M Morren","year":"2007","unstructured":"Morren M, Rijken M, Baanders AN, Bensing J (2007) Perceived genetic knowledge, attitudes towards genetic testing, and the relationship between these among patients with a chronic disease. Patient Educ Couns 65:197\u2013204","journal-title":"Patient Educ Couns"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-009-9313-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-009-9313-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-009-9313-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:46:01Z","timestamp":1559252761000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-009-9313-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,20]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9313"],"URL":"https:\/\/doi.org\/10.1007\/s10689-009-9313-1","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,20]]}}}